Les Laboratoires Servier
Overview
For patients suffering from heart disease, Les Laboratoires Servier is at their service. Servier is an independent, French pharmaceutical company which manufactures and sells drugs to combat cardiovascular diseases, such as coronary artery disease, hypertension, and stroke. Cardiovascular drugs account for about two-thirds of the company's annual revenues. It also produces medicines to treat diabetes, venous disease, and cancer. Annually, more than 700 million boxes of drugs are produced by Servier. Its pharmaceutics can be found in 140 countries; 80% of its sales are generated internationally.
Key Numbers from Hoover's UK
Key financials for Les Laboratoires Servier
| Company Type | Private |
|---|---|
| Fiscal Year-End | December |
TIP: Understand how a company performs against its industry by reviewing Comparison Data. Column-to-column comparisons to the industry and the market are available with a Hoover's subscription.
TIP: Subscribers have access to detailed financial data (income statement, balance sheet, cash flow) for more than 500,000 public and private companies in the UK.
Key People from Hoover's UK
Key people and executives for Les Laboratoires Servier
| Chairman | Jacques Servier (Subscribers see complete biographies -- view sample)
|
|---|---|
| CEO | Jean-Philippe Seta |
| Director Technology | Ange Diaz |
TIP: Use Build Executive List to target decision makers by industry, geography, sales, net income, and number of employees.
Top Competitors from Hoover's UK
Top competitors of Les Laboratoires Servier
There are 8 competitors for Servier; see more.TIP: Analyze the Competitive Landscape to view a head-to-head comparison of a firm's profitability, operations, growth, and valuation versus that of its top three competitors.
Industry Information from Hoover's UK
First Research Industry Profiles Extensive Industry Intelligence
Hoover's Industries
More Industry InformationTIP: Hoover's proprietary industry structure allows you to tell at-a-glance how diversified a company's operations are, and which line of business can be considered a company's primary industry.
